AVIEW Lung Cancer Screening (LCS) is a medical imaging AI software that provides automated lung nodule detection, segmentation, and analysis from Low-Dose CT chest images.
The Coreline LCS program has been the sole official solution selected from the ‘K-LUCAS’ (Korean Lung Cancer Screening) from its pilot project period of the YR 2017-2018 and its full-out screening YR 2019 till now.
Since 2019, with its full-out screening program, Coreline has been working with more than 300 hospitals (50 of which are connected to the ‘National Cloud’ with the Central Data repository system).
Big 3 thoracic diseases are;
We are the Official solution provider for:
- The nationwide lung cancer screening program in Korea (K-Lucas) from 2017, which is the 2nd state-level-reimbursed LCS program following the US from 2015
- 4-ITLR project by the Nelson Team (Erasmus MC and iDNA in the Netherlands), which is a large early detection LCS trial on LCS+ system. Two hospitals in Germany, DKFZ Heidelberg and University Hospital of Essen, are the members of this trial and our systems will be implemented in these hospitals from 2021
- The German trial by multi-university hospitals which is a pilot project to prove the need for the national support for lung cancer screening in Germany